Tempus AI unit Ambry Genetics launches GenomeNext whole — genome sequencing test for rare diseases
Ambry Genetics, a Tempus AI subsidiary, launched GenomeNext, a whole-genome sequencing test aimed at improving rare-disease diagnosis. GenomeNext uses a pangenome reference to improve variant detection across diverse ancestral backgrounds. GenomeReveal adds integrated RNA analysis to support interpretation of certain D